Yüklüyor......
Understanding how long‐acting β(2)‐adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma – an update
In moderate‐to‐severe asthma, adding an inhaled long‐acting β(2)‐adenoceptor agonist (LABA) to an inhaled corticosteroid (ICS) provides better disease control than simply increasing the dose of ICS. Acting on the glucocorticoid receptor (GR, gene NR3C1), ICSs promote anti‐inflammatory/anti‐asthma ge...
Kaydedildi:
| Yayımlandı: | Br J Pharmacol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5120156/ https://ncbi.nlm.nih.gov/pubmed/27646470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13628 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|